Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

Yes, I love this drug ever since I discovered this company while I was screening for my CV19 plays. The TRIDENT 3-in-1 action approach being an immunoregulator drug that it was a huge plus and a distinct advantage over those protease inhibitors that are being repurposed. Leave no stones unturned regardless of where the company is listed. Simply put, the compound HDMs work in all types of pandemics, and the MOA if its antiviral is more likely being evaluated by that University? JHU or Pennsylvania U?

The results are going to be good if not great with Bril's amphiphilic ability to bind to S-protein to inhibit viral entry to host cells via ACE2, but also degenerates the E-membrane of SARsCoV2 to inhibit viral replications. Jmha and opinion.

Funding could amount to 40m to 60m or more since Bril has the potential to be an adjuvant to oral any vaccine, if not a stand-alone and/or combination drug. So I totally agreed with you. The best risk to reward investment play for all cv19 therapeutic drugs. There's no doubt in my mind that this drug will work! GLTA!